Western Australian auditor general has found significant weaknesses in the state's public pathology provider, which stores nearly 14 million medical test results conducted in 2023-24.
A Perth-based medtech company has been granted its first patent over a test which it believes can slash the time it takes to diagnose endometriosis from seven years to just a few weeks.Proteomic
NeuroScientific has completed its acquisition of fellow Perth pharmaceuticals company Isopogen WA, which controls the patent for StemSmart technology, in a bid to boost its stem cell offerings.T
Cybersecurity experts are warning the recent hack of a WA-based engineering contractor highlights the vulnerabilities within resources and defence supply chains.
A preliminary report into the tech which will enforce the Albanese government's social media ban has found it is ‘robust', but warned of privacy and security concerns.
The Auditor General's report on the state's major IT projects found the information given to the public to be patchy and inconsistent, including a $1.6 billion cost discrepancy.
Perth-based neurological drug developer Argenica Therapeutics has been knocked back by the US Food and Drug Administration, dashing hopes its US clinical trials would soon start.
Escalante-backed icetana AI has inked a partnership deal with leading global tech company SoftBank Robotics, as it gears up to enter Japan.The multi-year partnership includes four strategic agre
The state government has awarded a tender to more than a dozen companies which will receive about $375 million worth of technology infrastructure work.
The Legal Practice Board of WA has become the latest target of a cyber attack, after hackers accessed bank details and other information of legal professionals.
A local cybersecurity and privacy partner has warned businesses not to ‘recklessly delay' investing in protecting their data following several cyberattacks in Perth.
Perth software companies INX Software and K2fly have completed their merger, rebranding as Quartex while also committing to remaining headquartered in Perth.
Murdoch-based Orthocell's push to expand the reach of its nerve repair product Remplir has continued, following news it has received regulatory approval in Hong Kong.